HER2 overexpression and amplification is present in a subset of ovarian mucinous carcinomas and can be targeted with trastuzumab therapy

Last 30 days: 86 accesses
Last 365 days: 727 accesses
All time: 2832 accesses

Jessica N McAlpine^*, Kimberly C Wiegand, Russell Vang, Brigitte M Ronnett, Anna Adamiak, Martin Köbel, Steve E Kalloger, Kenneth D Swenerton, David G Huntsman, C B Gilks and Dianne M Miller